UPDATE: Bank Of America Downgrades Sagent Pharmaceuticals On Potential Near-Term Volatility
July 25, 2014 at 10:01 AM EDT
In a report published Friday, Bank of America analyst Sumant S. Kulkarni downgraded the rating on Sagent Pharmaceuticals (NASDAQ: SGNT) ...